A randomised controlled trial of intravenous steroids at home versus outpatients department for treatment of acute multiple sclerosis relapses

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN95588376

Enrollment

164

Registered

2003-09-12

Start date

2002-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases: Multiple sclerosis (MS) Nervous System Diseases

Interventions

Treatment in outpatients department versus home

Eligibility

Inclusion criteria

Inclusion criteria: 164 Patients from Neurology.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Patient and carer perception of management of MS relapse.	—

Secondary

Measure	Time frame
Other measures include patients' safety, MS impact scores and cost of health case resources.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026